Stay updated on Long-term Safety of KarXT in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.

Latest updates to the Long-term Safety of KarXT in Schizophrenia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew Revision: v3.4.2 added to the history and the temporary government-funding status notice (v3.4.1) was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedSite-wide funding notice was added and the record version updated to v3.4.1, replacing v3.4.0. These are minor metadata updates and do not affect study data, eligibility, or results.SummaryDifference0.8%

- Check28 days agoChange DetectedThe history page now shows a glossary toggle, green/red color-coded diffs, and updated version labels (No FEAR Act Data and Revision: v3.4.0), replacing the previous No FEAR Act data and Revision: v3.3.4. These are formatting and metadata changes and do not alter the core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) was added to the Record History, replacing the previous revision (v3.3.3). The visible content and study details remain unchanged.SummaryDifference0.1%

- Check63 days agoChange DetectedA new version entry 'Revision: v3.3.3' was added to the history, and two items—'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'—were removed; these are routine page maintenance updates and do not alter the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedNew revision version v3.3.2 appears in the Record History, replacing v3.2.0, and the visible study data and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Long-term Safety of KarXT in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.